Awarded a patent

Apr 6, 2024

The Center for Advanced Neurological Research, KSHEMA was awarded a patent in April 2024, for the development of a sensitive cell based assay for detection of myelin oligodendrocyte glycoprotein antibody (MOG IgG). This is the second patent awarded to the Center for its original research and contributions.